Literature DB >> 16188521

Pacemaker utilization during permanent atrial fibrillation in patients who received pacemaker implantation for sinus node dysfunction.

Huagui Li1, Dhanunjaya Lakkireddy, Hema Korlakunta, Karen Rovang, Tom Hee.   

Abstract

Patients who have pacemakers and sinus node dysfunction frequently have atrial fibrillation (AF). The need for continued pacemaker therapy after conversion to permanent AF remains uncertain. This study showed that, among 174 patients who received pacemaker implantation for sinus node dysfunction, 38% (n = 62) had the minimum intrinsic ventricular rate of >60 beats/min after conversion to AF. The pacemaker memory showed that 30 patients (18%) never used ventricular pacing during permanent AF. The study results suggest that patients who have a stable intrinsic ventricular rate during permanent AF by serial assessment may no longer need continued pacemaker therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16188521     DOI: 10.1016/j.amjcard.2005.05.065

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Risk factors for bradycardia requiring pacemaker implantation in patients with atrial fibrillation.

Authors:  Tyler W Barrett; Robert L Abraham; Cathy A Jenkins; Stephan Russ; Alan B Storrow; Dawood Darbar
Journal:  Am J Cardiol       Date:  2012-07-26       Impact factor: 2.778

Review 2.  [Bachmann bundle pacing].

Authors:  C W Israel; T Burmistrava; C Berger
Journal:  Herz       Date:  2018-11       Impact factor: 1.443

3.  Pacemaker implantation after catheter ablation for atrial fibrillation.

Authors:  Abhishek J Deshmukh; Xiaoxi Yao; Stephanie Schilz; Holly Van Houten; Lindsey R Sangaralingham; Samuel J Asirvatham; Paul A Friedman; Douglas L Packer; Peter A Noseworthy
Journal:  J Interv Card Electrophysiol       Date:  2015-11-06       Impact factor: 1.900

4.  Risk factors and a 3-month risk score for predicting pacemaker implantation in patients with atrial fibrillations.

Authors:  Frederik Dalgaard; Jannik Langtved Pallisgaard; Tommi Bo Lindhardt; Gunnar Gislason; Paul Blanche; Christian Torp-Pedersen; Martin H Ruwald
Journal:  Open Heart       Date:  2020-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.